OXFORD, England –– LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a palm-sized device, MinION Mk1C. Following an application to the UK’s MHRA, the LamPORE assay is now CE marked for in vitro […]
SEATTLE– NanoString Technologies Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a key milestone in their partnership to develop new analysis tools to accelerate research on NanoString’s nCounter® Analysis System. After successful completion of an Early Access Program […]
We have added a Sequel II system from Pacific Biosciences to our Next Generation Sequencing facilities. The new platform widens our possibilities to optimally support partners in answering their toughest research questions in crop innovation. At KeyGene, next to our strategic focus on the Oxford Nanopore Technologies platforms, we continue to invest in NGS technologies […]
ERS scientific advisor and co-founder received award jointly with Jennifer A. Doudna, for ‘the development of a method for genome editing’ Dublin, Ireland – ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Professor Emmanuelle Charpentier, congratulates Emmanuelle on being awarded the 2020 Nobel Prize in Chemistry […]
REDWOOD CITY, Calif. — Synthego, the genome engineering company, today announced the design of new foundational technology for standardized precision and control of CRISPR-based gene editing inside cells using light. Described in Nature Communications, Synthego researchers developed a new class of guide molecules, CRISPRoff™, a synthetic sgRNA that fragments in response to light, enabling precise temporal and […]
HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products today announced the global launch of its CFX Opus 96 and CFX Opus 384 Real-time PCR Systems along with BR.io, a cloud-based instrument connectivity, data management, and analysis platform. The CFX Opus 96 and CFX […]
SCOTTSDALE, Ariz. — PathogenDx, Inc., an Arizona based technology company which has developed a multiplexed microarray DNA-based pathogen testing platform, announced today that its EnviroX-f, an ultra-rapid microarray test designed for food safety, has earned an AOAC® Performance Tested Methods SM (PTM) Certificate from the AOAC Research Institute. EnviroX-f is the world’s first multiplex Salmonella, Listeria spp and […]
Highest Data Quality Bolsters Large Scale Studies ANN ARBOR, Mich — Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits introduces the new Swift 2S Sonic DNA Library Kit to the NGS Industry. After a tremendously successful debut of Swift 2S Turbo’s low-cost enzymatic fragmentation-based library preparation kit, Swift […]
The UK genomic tools developer, RevoluGen Ltd. (‘RevoluGen or the Company), today announces it has entered into a non-exclusive distribution agreement with Welgene Biotech Co., Ltd. (‘Welgene’) of Taiwan, for the distribution of its Fire Monkey/Fire Flower High Molecular Weight DNA (HMW-DNA) extraction and purification product. Under the terms of the agreement, RevoluGen has granted […]
Signs Agreement to Acquire ReadCoor; Acquires Sweden’s CartaNA AB PLEASANTON, Calif. — Continuing on its mission of mastering biology to advance human health, 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a definitive agreement to acquire ReadCoor, Inc., developer of foundational In Situ technologies, based in Boston, for cash and stock consideration of $350 […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
